Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
NCT ID: NCT05112198
Last Updated: 2025-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
41 participants
INTERVENTIONAL
2018-03-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Web-based Collaborative Care Intervention Study
NCT02939755
SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention
NCT02779725
A Computer-Based System for Symptom Reporting in Patients With Cancer Undergoing Treatment
NCT03979846
Remote COVID-19 Symptom Tracking for Cancer Patients at Home During the Pandemic
NCT04464486
Internet Support for Cancer Patients
NCT00710658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients who express interest and ability to participate will be interviewed to determine eligibility.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Noona web-based symptom tracking tool
In addition to usual care for their disease, patients interact with Noona system and system questioners to record their symptoms over a period of 6 months.
Use of Noona web- based symptom tracking tool
Noona patient reported outcome (PRO) platform tool that summarizes symptoms and distress
Usual Care
Participants will receive the standard of care for their disease
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Use of Noona web- based symptom tracking tool
Noona patient reported outcome (PRO) platform tool that summarizes symptoms and distress
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Biopsy proven (recurrent or metastatic) advanced lung or gastrointestinal cancer
3. No limit on prior lines of therapy in the metastatic setting
4. ECOG performance status of 0-2
5. Estimated life expectancy of at least 6 months
6. Access to smartphone, tablet or computer with capability to utilize symptom tracking application
7. Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any research-related procedures
8. Willing and able to comply with all study procedures
Exclusion Criteria
2. Non-english speaking, as the application is developed in the english language
3. Non-castrate resistant prostate cancer
4. Enrolled in other non-therapeutic or therapeutic clinical trials
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Varian Medical Systems
INDUSTRY
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kavitha Ramchandran, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stanford Cancer Institute
Palo Alto, California, United States
UCSF Helen Diller Medical Center
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2021-12414
Identifier Type: OTHER
Identifier Source: secondary_id
IRB-38423
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.